Drug Information

Drug General Information
Drug ID
D0I8BO
Former ID
DNC013997
Drug Name
1-(5-(furan-2-yl)oxazol-2-yl)octadec-9-en-1-one
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529594]
Formula
C25H37NO3
Canonical SMILES
CCCCCCCCC=CCCCCCCCC(=O)C1=NC=C(O1)C2=CC=CO2
InChI
1S/C25H37NO3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-18-22(27)25-26-21-24(29-25)23-19-17-20-28-23/h9-10,17,19-21H,2-8,11-16,18H2,1H3/b10-9-
InChIKey
RZGSPAWMLKONHZ-KTKRTIGZSA-N
PubChem Compound ID
11361560
Target and Pathway
Target(s) Fatty-acid amide hydrolase Target Info Inhibitor [529594]
BioCyc Pathway Anandamide degradation
KEGG Pathway Retrograde endocannabinoid signaling
PANTHER Pathway Anandamide degradation
References
Ref 529594J Med Chem. 2008 Aug 14;51(15):4392-403. Epub 2008 Jul 16.Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase.
Ref 529594J Med Chem. 2008 Aug 14;51(15):4392-403. Epub 2008 Jul 16.Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.